Cotadutide vs Oxyntomodulin

Head-to-head comparison of Cotadutide (MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist) and Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyCotadutideOxyntomodulin
CategoryWeight ManagementWeight Management
Full NameMEDI0382, long-acting GLP-1 and glucagon receptor dual agonistEndogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Molecular Weight~4,700 Da~4,200 Da
Half-LifeApproximately 24 hours12-15 minutes
Amino Acids3737
Typical Dose0.3-3 mg daily in clinical studiesResearch doses vary; commonly 100-300 mcg in small human studies
RouteSubcutaneousSubcutaneous/IV
Purity≥98%≥98%
Studies Count1880
Research StatusClinicalClinical

Cotadutide Benefits

  • body-weight reduction
  • improved insulin sensitivity
  • reduced hepatic fat
  • appetite suppression

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

Cotadutide Dosing

Once-daily SC in trials|Start low and titrate based on tolerance|Monitor GI adverse effects

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

Cotadutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Research Overview

Cotadutide

Phase 2 studies reported dose-dependent weight loss and favorable changes in glycemic and liver-related markers. It is one of the most cited synthetic dual-agonist peptides for obesity research.

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Cotadutide stacks with:

dietary-calorie-restrictionexercise-program

Oxyntomodulin stacks with:

calorie-deficitresistance-training
GLP-1glucagon-coagonistdual-agonistobesity-researchendogenous-peptideappetite-regulation